211 related articles for article (PubMed ID: 28024582)
1. Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.
Aniagyei SE; Sims LB; Malik DA; Tyo KM; Curry KC; Kim W; Hodge DA; Duan J; Steinbach-Rankins JM
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():238-251. PubMed ID: 28024582
[TBL] [Abstract][Full Text] [Related]
2. Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.
Tyo KM; Vuong HR; Malik DA; Sims LB; Alatassi H; Duan J; Watson WH; Steinbach-Rankins JM
Int J Pharm; 2017 Oct; 531(1):118-133. PubMed ID: 28797967
[TBL] [Abstract][Full Text] [Related]
3. Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.
Grooms TN; Vuong HR; Tyo KM; Malik DA; Sims LB; Whittington CP; Palmer KE; Matoba N; Steinbach-Rankins JM
Antimicrob Agents Chemother; 2016 Nov; 60(11):6518-6531. PubMed ID: 27550363
[TBL] [Abstract][Full Text] [Related]
4. pH-responsive delivery of Griffithsin from electrospun fibers.
Tyo KM; Duan J; Kollipara P; Dela Cerna MVC; Lee D; Palmer KE; Steinbach-Rankins JM
Eur J Pharm Biopharm; 2019 May; 138():64-74. PubMed ID: 29698714
[TBL] [Abstract][Full Text] [Related]
5. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection.
Steinbach JM; Weller CE; Booth CJ; Saltzman WM
J Control Release; 2012 Aug; 162(1):102-10. PubMed ID: 22705461
[TBL] [Abstract][Full Text] [Related]
6. Controlled release and antiviral activity of acyclovir-loaded PLA/PEG nanofibers produced by solution blow spinning.
Ferreira KN; Oliveira RR; Castellano LRC; Bonan PRF; Carvalho OV; Pena L; Souza JR; Oliveira JE; Medeiros ES
Biomater Adv; 2022 May; 136():212785. PubMed ID: 35929318
[TBL] [Abstract][Full Text] [Related]
7. Comparative Study of Poly (ε-Caprolactone) and Poly(Lactic-co-Glycolic Acid) -Based Nanofiber Scaffolds for pH-Sensing.
Di W; Czarny RS; Fletcher NA; Krebs MD; Clark HA
Pharm Res; 2016 Oct; 33(10):2433-44. PubMed ID: 27380188
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
9. Preparation and properties of nanosized biodegradable polymer capsules.
Sakai H; Sekita A; Tanaka K; Sakai K; Kondo T; Abe M
J Oleo Sci; 2011; 60(11):569-73. PubMed ID: 22027022
[TBL] [Abstract][Full Text] [Related]
10. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
11. Ocular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovir.
Jwala J; Boddu SH; Shah S; Sirimulla S; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2011 Apr; 27(2):163-72. PubMed ID: 21500985
[TBL] [Abstract][Full Text] [Related]
12. Amniotic epithelial stem cell biocompatibility for electrospun poly(lactide-co-glycolide), poly(ε-caprolactone), poly(lactic acid) scaffolds.
Russo V; Tammaro L; Di Marcantonio L; Sorrentino A; Ancora M; Valbonetti L; Turriani M; Martelli A; Cammà C; Barboni B
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():321-9. PubMed ID: 27612719
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity against Zika virus of a new formulation of curcumin in poly lactic-co-glycolic acid nanoparticles.
Pacho MN; Pugni EN; Díaz Sierra JB; Morell ML; Sepúlveda CS; Damonte EB; García CC; D'Accorso NB
J Pharm Pharmacol; 2021 Mar; 73(3):357-365. PubMed ID: 33793877
[TBL] [Abstract][Full Text] [Related]
14. Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies.
Dobhal A; Srivastav A; Dandekar P; Jain R
J Mater Sci Mater Med; 2021 Sep; 32(10):126. PubMed ID: 34591178
[TBL] [Abstract][Full Text] [Related]
15. Preparation of cylinder-shaped porous sponges of poly(L-lactic acid), poly(DL-lactic-co-glycolic acid), and poly(ε-caprolactone).
He X; Kawazoe N; Chen G
Biomed Res Int; 2014; 2014():106082. PubMed ID: 24719843
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir.
Snejdrova E; Drastik M; Dittrich M; Kastner P; Nguyenova J
Drug Dev Ind Pharm; 2016 Oct; 42(10):1653-9. PubMed ID: 26925606
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
[TBL] [Abstract][Full Text] [Related]
18. Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.
de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S
J Control Release; 2001 Jul; 75(1-2):191-7. PubMed ID: 11451509
[TBL] [Abstract][Full Text] [Related]
19. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
20. Computational Modeling of Antiviral Drug Diffusion from Poly(lactic- co-glycolic-acid) Fibers and Multicompartment Pharmacokinetics for Application to the Female Reproductive Tract.
Halwes ME; Tyo KM; Steinbach-Rankins JM; Frieboes HB
Mol Pharm; 2018 Apr; 15(4):1534-1547. PubMed ID: 29481088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
